This document constitutes three base prospectuses for the purposes of Art. 5.4 of Directive 2003/71/EC: (i) the base prospectus for Siemens Aktiengesellschaft in respect of non-equity securities within the meaning of Article 22 no. 6 (4) of the Commission Regulation (EC) No. 809/2004 of April 29, 2004, as amended, (“Non-Equity Securities”), (ii) the base prospectus for Siemens Capital Company LLC in respect of Non-Equity Securities, and (iii) the base prospectus for Siemens Financieringsmaatschappij N.V. in respect of Non-Equity Securities (together, “Prospectus”). SIEMENS AKTIENGESELLSCHAFT (A stock corporation incorporated with limited liability in the Federal Republic of Germany) as Issuer of Instruments and as Guarantor for Instruments issued by Siemens Capital Company LLC and Siemens Financieringsmaatschappij N.V. SIEMENS CAPITAL COMPANY LLC (A limited liability company organized under the laws of the State of Delaware, United States of America) as Issuer of Instruments SIEMENS FINANCIERINGSMAATSCHAPPIJ N.V. (A public company incorporated with limited liability in the Netherlands) as Issuer of Instruments €15,000,000,000 PROGRAMME FOR THE ISSUANCE OF DEBT INSTRUMENTS Application has been made to the Luxembourg Stock Exchange for debt instruments (“Instruments”) issued under the €15,000,000,000 programme for the issuance of debt instruments (“Programme”) up to the expiry of 12 months after the date of publication hereof to be listed on the official list of the Luxembourg Stock Exchange and admitted to trading on the Luxembourg Stock Exchange’s regulated market (“Luxembourg Stock Exchange’s Regulated Market”), which is a regulated market for the purposes of Directive 2004/39/EC on Markets in Financial Instruments amending Council Directives 85/611/EEC and 93/6/EEC and Directive 2000/12/EC of the European Parliament and of the Council and repealing Council Directive 93/22/EEC. However, Instruments may also be issued under the Programme which are listed and traded on another stock exchange or which will not be listed and traded on any stock exchange. The maximum aggregate principal amount of Instruments outstanding under the Programme will not exceed €15,000,000,000. The Guarantor has unconditionally and irrevocably guaranteed to Luther Rechtsanwaltsgesellschaft mbH, acting as trustee for the holders of Instruments, the proper payment of all amounts due under the Instruments issued by Siemens Capital Company LLC and Siemens Financieringsmaatschappij N.V. Prospective purchasers of the Instruments should in particular refer to Important Notice beginning on page 1 and to Risk Factors in Part C of this Prospectus. This Prospectus has been approved by the Commission de Surveillance du Secteur Financier of the Grand Duchy of Luxembourg (“CSSF”) in its capacity as competent authority under the Luxembourg law of July 10, 2005, relating to prospectuses for securities (Loi relative aux prospectus pour valeurs mobilières – “Luxembourg Prospectus Law”) and will be published on the website of the Luxembourg Stock Exchange (www.bourse.lu). Each Issuer has requested the CSSF to provide the competent authorities in the Federal Republic of Germany (“Germany”), the United Kingdom of Great Britain and Northern Ireland, The Netherlands and the Republic of Austria with a certificate of approval attesting that the Prospectus has been drawn up in accordance with the Luxembourg Prospectus Law. Arranger MORGAN STANLEY Dealers BARCLAYS BofA MERRILL LYNCH CREDIT SUISSE DEUTSCHE BANK GOLDMAN SACHS INTERNATIONAL J.P. MORGAN MORGAN STANLEY UBS INVESTMENT BANK May 8, 2012 RESPONSIBILITY STATEMENT Each of Siemens Aktiengesellschaft with its registered offices in Munich and Berlin, Germany, Siemens Capital Company LLC with its registered office in Wilmington, Delaware, USA and Siemens Financieringsmaatschappij N.V. with its registered office in The Hague, The Netherlands (each “Issuer” and together, “Issuers”) (in each case in relation to itself and in respect of the Instruments issued by itself only) and Siemens Aktiengesellschaft in its capacity as guarantor (“Guarantor”) (in relation to itself and the Instruments only) accepts responsibility for the information contained in this Prospectus provided however that with regard to the information contained in the description of each relevant Issuer only such Issuer accepts responsibility. The CSSF assumes no responsibility as to the economic and financial soundness of the transactions under the Programme and the quality or solvency of the Issuers in line with the provisions of article 7 (7) of the Luxembourg Prospectus Law. Each of the Issuers and the Guarantor declare that, having taken all reasonable care to ensure that such is the case, the information contained in this Prospectus for which it is responsible is, to the best of their knowledge, in accordance with the facts and contains no omission likely to affect the import of such information. IMPORTANT NOTICE Prospectus This Prospectus should be read and construed together with any supplement(s) thereto and with any other documents incorporated by reference herein. In relation to any Tranches (as defined herein) of Instruments, this Prospectus has in addition to be read and construed together with the relevant Final Terms (as defined herein). Exclusiveness No person has been authorised to give any information which is not contained in or not consistent with this Prospectus or information supplied in connection with the Programme and, if given or made, such information should not be relied upon as having been authorised by or on behalf of the Issuers, the Guarantor, the Dealers (as defined below) or any of them. No Responsibility of the Dealers The arranger and the dealers (including any further dealer appointed according to the dealership agreement relating to the Programme dated May 8, 2012 (“Dealers”)) do not make any representation or warranty or accept any responsibility, as to the accuracy or completeness of the information contained in this Prospectus. Non-Significance of Delivery Neither the delivery of this Prospectus or any Final Terms nor the offering, sale or delivery of any Instrument, in any circumstances, creates any implication that the information contained in this Prospectus is true subsequent to the date thereof or the date upon which this Prospectus has been most recently supplemented or that there has been no adverse change in the financial situation of any of the Issuers or the Guarantor since the date thereof or, as the case may be, the date upon which this Prospectus has been most recently supplemented. Restriction on Distribution, Offer and Sale Law may restrict the distribution of this Prospectus, any supplement(s) thereto and any Final Terms and the offering, sale and delivery of the Instruments in certain jurisdictions. Persons into whose possession this Prospectus, any supplement(s) thereto or any Final Terms fall, are required to inform themselves about and to observe any such restrictions. For a description of certain restrictions on offers, sales and deliveries of Instruments and on the distribution of this Prospectus, any supplement(s) thereto or any Final Terms and other offering material relating to the Instruments, see “Part I: Subscription and Sale”. Neither the Instruments nor the SCC Guarantee (as defined herein) nor the SFM Guarantee (as defined herein) have been, or will be, registered under the United States Securities Act of 1933, as amended (“Securities Act”), and the Instruments may include Instruments in bearer form that are subject to U.S. Tax Law requirements. Accordingly, the Instruments are being offered and sold only 1 outside the United States of America (as such term is defined in Regulation S under the Securities Act (“Regulation S”)) to non-U.S. persons in reliance on Regulation S. For further details, see “Part I: Subscription and Sale”. The Instruments have not been approved or disapproved by the Securities and Exchange Commission or any state securities commission in the United States of America nor has the Securities and Exchange Commission or any state securities commission in the United States of America passed upon the accuracy or the adequacy of this Prospectus. Any representation to the contrary is a criminal offense in the United States of America. Neither this Prospectus nor any supplement(s) thereto nor any Final Terms may be used for the purpose of an offer or solicitation by anyone in any jurisdiction in which such offer or solicitation is not authorized or to any person to whom it is unlawful to make such an offer or solicitation. Stabilization In connection with the issue of any Tranche of Instruments, the Dealer or Dealers (if any) named as stabilizing managers (“Stabilizing Managers”) (or persons acting on behalf of any Stabilizing Manager(s)) in the applicable Final Terms may over-allot Instruments or effect transactions with a view to supporting the market price of the Instruments at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilizing Manager(s) (or person(s) acting on behalf of (a) Stabilizing Manager(s)) will undertake stabilization action. Any stabilization action may begin on or after the date on which adequate public disclosure of the terms of the offer of the relevant Tranche of Instruments is made and, if begun, may be ended at any time, but it must end no later than the earlier of 30 days after the issue date of the relevant Tranche of Instruments and 60 days after the date of the allotment of the relevant Tranche